blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1149842

EP1149842 - Somatostatin antagonists and agonists that act at the sst subtype 2 receptor [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.07.2003
Database last updated on 17.05.2024
Most recent event   Tooltip04.07.2003Application deemed to be withdrawnpublished on 20.08.2003  [2003/34]
Applicant(s)For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
[N/P]
Former [2001/44]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, Connecticut 06340 / US
Inventor(s)01 / Cole, Bridget McCarthy
Pfizer Global Res. and Dev., Eastern Point Road
Groton, Connecticut 06340 / US
02 / Hay, Bruce Allan
Pfizer Global Res. and Dev., Eastern Point Road
Groton, Connecticut 06340 / US
03 / Ricketts, Anthony Paul
Pfizer Global Res. and Dev., Eastern Point Road
Groton, Connecticut 06340 / US
 [2001/44]
Representative(s)Wood, David John, et al
Pfizer Limited European Patents Department, Ramsgate Road, Sandwich
Kent CT13 9NJ / GB
[N/P]
Former [2001/44]Wood, David John, et al
PFIZER LIMITED, European Patents Department, Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date01303553.019.04.2001
[2001/44]
Priority number, dateUS20000200319P28.04.2000         Original published format: US 200319 P
[2001/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1149842
Date:31.10.2001
Language:EN
[2001/44]
Type: A3 Search report 
No.:EP1149842
Date:31.07.2002
[2002/31]
Search report(s)(Supplementary) European search report - dispatched on:EP19.06.2002
ClassificationIPC:C07K5/068, C07K5/09, A61K38/05, A61K38/06, A61P5/02
[2001/44]
CPC:
C07K5/0808 (EP,US); A61P1/04 (EP); A61P17/00 (EP);
A61P3/08 (EP); A61P37/04 (EP); A61P43/00 (EP);
A61P5/02 (EP); A61P5/06 (EP); A61P5/08 (EP);
C07K5/021 (EP,US); C07K5/06078 (EP,US); C07K5/06156 (EP,US);
C07K5/06191 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2001/44]
TitleGerman:Somatostatin-Antagonisten und -Agonisten, die auf den SST-Sybtyp-Receptor wirken[2001/44]
English:Somatostatin antagonists and agonists that act at the sst subtype 2 receptor[2001/44]
French:Antagonistes et Agonistes de Somatostatine agissant sur le récepteur de subtype SST[2001/44]
Examination procedure30.04.2001Examination requested  [2001/44]
01.02.2003Application deemed to be withdrawn, date of legal effect  [2003/34]
12.03.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2003/34]
Fees paidPenalty fee
Additional fee for renewal fee
30.04.200303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PA]EP1086947  (PFIZER PROD INC [US]) [PA] 1-33 * the whole document *
 [A]  - PASTERNAK A ET AL, "Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclization", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19990208), vol. 9, no. 3, ISSN 0960-894X, pages 491 - 496, XP004157253 [A] 1-33 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0960-894X(99)00016-5
 [A]  - YANG L ET AL, "SYNTHESIS AND BIOLOGICAL ACTIVITIES OF POTENT PEPTIDOMIMETICS SELECTIVE FOR SOMATOSTATIN RECEPTOR SUBTYPE 2", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (199809), vol. 95, ISSN 0027-8424, pages 10836 - 10841, XP002916393 [A] 1-33 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.95.18.10836
 [A]  - ROHRER SUSAN P ET AL, "Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.", SCIENCE (WASHINGTON D C), (19981023), vol. 282, no. 5389, ISSN 0036-8075, pages 737 - 740, XP002189092 [A] 1-23,26 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.282.5389.737
 [DA]  - YANG L ET AL, "Spiro[1H-indene-1,4-piperidine] Derivatives as Potent and Selective Non-Peptide Human Somatostatin Receptor Subtype 2 (SST2) Agonists", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19980618), vol. 41, no. 13, ISSN 0022-2623, pages 2175 - 2179, XP002153464 [DA] 1-33 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm980194h
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.